NSE filing, NSE: EMCURE. Summary written from the filing by ALFA Finder's alert engine.
Emcure Pharmaceuticals Ltd: key numbers
- Share price
- ₹1,871.80
- Market cap
- ₹35,510 Cr
- Revenue (annual)
- ₹9,204 Cr
- Net profit (annual)
- ₹924.4 Cr
- P/E (TTM)
- 35.1×Sector 45.9×
- Promoter holding
- 77.82%-0.01% QoQ
- FII holding
- 4.94%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Emcure Pharmaceuticals Ltd
All →Emcure Pharmaceuticals Other Announcement
Emcure Pharmaceuticals submitted its quarterly shareholding pattern for the period ended September 30, 2026. This filing is a routine regulatory compliance disclosure under SEBI.
Emcure Pharmaceuticals Board Meeting Date
Emcure Pharmaceuticals will hold a board meeting on November 03, 2026, to consider and approve the company's standalone and consolidated financial results for the quarter.
Emcure Pharmaceuticals Acquisition
Emcure Pharmaceuticals approved the merger of its wholly-owned subsidiaries, Zuventus Healthcare and Emcutix Biopharmaceuticals, into itself. The internal restructuring involves no cash consideration or share issuance.
Emcure Pharmaceuticals Legal & Regulatory
Emcure Pharmaceuticals received Income-tax Department orders imposing aggregate penalties of Rs. 57.74 Crore for assessment years 2015-16 to 2021-22. The company is evaluating legal remedies.
- Value
- ₹57.74 Cr
Emcure Pharmaceuticals Investor Presentation: Key Takeaways
Emcure reported strong Q1 FY27 momentum with revenue of INR 92,035 Mn and PAT of INR 9,413 Mn for FY26. Strategy focuses on chronic-led domestic expansion and differentiated international portfolios.
Emcure Pharmaceuticals Annual General Meeting
Emcure Pharmaceuticals held its 45th Annual General Meeting on September 21, 2026. The meeting transacted ordinary and special business, including the approval of a final dividend.
Other share pledge announcements
All →Emami Share Pledge
Diwakar Finvest disclosed a pledge of 21.40 lakh Emami shares and a release of 41 lakh shares under Regulation 31. The filing states no monetary value.
Paisalo Digital Share Pledge
Promoter group entity Equilibrated Venture Cflow released pledge on 20 lakh Paisalo Digital shares worth ₹15.88 Crore. Shareholding remains unchanged at 20.64%.
- Value
- ₹15.88 Cr
Refex Industries Share Pledge
Refex Holding pledged shares to multiple entities, raising encumbered stake to 29.06% of capital. Pledged shares now total 51.37% of promoter holding.
Ginni Filaments Share Pledge
SBICAP Trustee released a pledge over 26,48,300 Ginni Filaments shares, cutting its stake to 9.06%. No cash changed hands in the encumbrance release.
Manipal Health Enterprises Share Pledge
Promoter entity MEMG International India Pvt Ltd released pledges over 72,50,000 and 72,42,951 shares of Manipal Health Enterprises. The 22 October 2026 release eases encumbrances in favour of Vistra ITCL and 360 One Prime.
Camlin Fine Sciences Share Pledge
Camlin Fine Sciences promoter-director Ashish Dandekar created pledges over 13.60 lakh shares worth ₹11.39 Cr. No change in shareholding; total pledged exposure rises for investors to monitor.
- Value
- ₹11.39 Cr